CRISPR Therapeutics AG
CRSP
$53.52
$1.883.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.17% | 23.58% | 3.14% | 11.30% | -7.23% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.62% | 3.76% | -39.76% | 10.67% | 1.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -89.72% | 11.14% | 0.00% | 0.00% |
| Total Current Assets | -3.13% | 23.30% | 2.93% | 11.27% | -7.17% |
|
|
|||||
| Total Current Assets | -3.13% | 23.30% | 2.93% | 11.27% | -7.17% |
| Net Property, Plant & Equipment | -2.98% | -2.72% | -3.10% | -2.70% | -2.65% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.30% | 0.16% | -3.26% | -10.70% | -62.21% |
| Total Assets | -2.75% | 20.33% | 0.89% | 10.62% | -6.30% |
|
|
|||||
| Total Accounts Payable | -17.15% | 22.53% | -5.59% | 20.97% | -25.34% |
| Total Accrued Expenses | 6.02% | -15.95% | 38.38% | -9.02% | -3.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.18% | 0.18% | 1.76% | 1.27% | 2.98% |
| Total Finance Division Other Current Liabilities | -3.77% | -11.63% | 32.72% | 30.05% | -18.78% |
| Total Other Current Liabilities | -3.77% | -11.63% | 32.72% | 30.05% | -18.78% |
| Total Current Liabilities | -2.49% | -8.61% | 25.36% | 13.98% | -12.63% |
|
|
|||||
| Total Current Liabilities | -2.49% | -8.61% | 25.36% | 13.98% | -12.63% |
| Long-Term Debt | 0.12% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.54% | -2.45% | -2.39% | -2.36% | -2.19% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.59% | -3.16% | -65.10% | 4.77% | 7.39% |
| Total Liabilities | -0.77% | 165.34% | 4.28% | 3.37% | -5.45% |
|
|
|||||
| Common Stock & APIC | 0.66% | 0.58% | 3.66% | 9.08% | 2.72% |
| Retained Earnings | -4.40% | -6.31% | -7.19% | -6.22% | -13.89% |
| Treasury Stock & Other | -134.33% | -142.03% | -3.35% | 23.80% | -2.31% |
| Total Common Equity | -3.75% | -5.58% | 0.30% | 11.97% | -6.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.75% | -5.58% | 0.30% | 11.97% | -6.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.75% | -5.58% | 0.30% | 11.97% | -6.45% |
|
|
|||||